Log in to save to my catalogue

Spinocerebellar ataxias: prospects and challenges for therapy development

Spinocerebellar ataxias: prospects and challenges for therapy development

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6469934

Spinocerebellar ataxias: prospects and challenges for therapy development

About this item

Full title

Spinocerebellar ataxias: prospects and challenges for therapy development

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Neurology, 2018-10, Vol.14 (10), p.590-605

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The spinocerebellar ataxias (SCAs) comprise more than 40 autosomal dominant neurodegenerative disorders that present principally with progressive ataxia. Within the past few years, studies of pathogenic mechanisms in the SCAs have led to the development of promising therapeutic strategies, especially for SCAs caused by polyglutamine-coding CAG repe...

Alternative Titles

Full title

Spinocerebellar ataxias: prospects and challenges for therapy development

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6469934

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6469934

Other Identifiers

ISSN

1759-4758

E-ISSN

1759-4766

DOI

10.1038/s41582-018-0051-6

How to access this item